Tag: first patient

May 10, 2018

Krystal Biotech Announces Dosing of First Patient in the Phase 1/2 trial of KB103

Krystal Biotech (NASDAQ:KRYS), a gene therapy company developing topical and intradermal “off-the-shelf” treatments for rare dermatological diseases, today announces that the...
April 18, 2018

Solid Biosciences Provides Update On SGT-001 Clinical Development Program For Duchenne Muscular Dystrophy

Solid Biosciences (NASDAQ:SLDB) announced that the Company has received a letter from the U.S. Food and Drug Administration (FDA) relating...
April 16, 2018

BeiGene Initiates Global Phase 2 Trial of Anti-PD-1 Antibody Tislelizumab in Patients with Relapsed or Refractory Mature T-and NK-Cell Lymphomas

BeiGene (NASDAQ:BGNE), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly targeted and immuno-oncology drugs for the treatment of...
April 10, 2018

BeiGene Initiates Global Phase 2 Trial of Anti-PD-1 Antibody Tislelizumab in Patients with Previously Treated Hepatocellular Carcinoma

BeiGene (NASDAQ:BGNE), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly targeted and immuno-oncology drugs for the treatment of...
April 9, 2018

Minerva Neurosciences Screens First Patient in Phase 2b Trial of MIN-117 to Treat Major Depressive Disorder

Minerva Neurosciences (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders,...
April 4, 2018

Moleculin Announces Patients Treated in FDA Approved Phase I/II Annamycin Clinical Trial

Moleculin Biotech (NASDAQ: MBRX) a clinical stage pharmaceutical company focused on the development of oncology drug candidates, all of which are...
April 4, 2018

Abiomed Announces European Approval (CE Marking) for Impella 5.5 and First Patient Treated at University Heart Center Hamburg

Abiomed (NASDAQ:ABMD), a leading provider of breakthrough heart recovery and support technologies, announced today that the Impella 5.5™ heart pump received...